Nyse bdx.

Becton, Dickinson and Company (NYSE:BDX) Q4 2023 Earnings Call Transcript November 9, 2023 Becton, Dickinson and Company reports earnings inline with expectations. Reported EPS is $3.42 EPS ...

Nyse bdx. Things To Know About Nyse bdx.

Shares of NYSE BDX traded up $2.09 during trading hours on Friday, hitting $238.89. The company’s stock had a trading volume of 780,792 shares, compared to its average volume of 1,700,525./PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it will report its fiscal 2023... BDX : 238.89 (+0.88%) Global Medical Device Packaging Market Size Expected to Reach $50 Billion By 2028 FinancialNewsMedia - Tue Sep 26, 9:00AM CDTSamsung’s stock is not listed on the NYSE and is only traded as a pink-sheet-listed share identifed as SSNLF. The South Korean-based technology company is only actively traded on the Korean Stock Exchange in which it is listed as 005930.KS.Founded in 1897 and headquartered in New Jersey, Becton, Dickinson and Company (NYSE:BDX) ranks 10th in our list of the best dialysis and kidney disease stocks to buy.

Becton, Dickinson and Company (NYSE:BDX) also raised its full-year profit forecast to between $12.10 and $12.32 from an initial target of between $12.07 and $12.32, signaling it is in the [ashes ...

Becton, Dickinson and Company's (NYSE: BDX) board approved the spinoff of its diabetes care business, which will be known as Embecta, and declared a pro rata distribution of Embecta shares of to ...

Overview Stock Screener Earnings Calendar Sectors NYSE | BDX U.S.: NYSE Becton Dickinson & Co. Watch list NEW Set a price target alert After Hours Last Updated: Dec 1, 2023 4:23 p.m. EST...FRANKLIN LAKES, N.J., Nov. 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Ronald (Ron) Silverman, MD ...FRANKLIN LAKES, N.J. (Oct. 1, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced Bridget Bagnato has been named president of BD Specimen Management, effective today. Bagnato will be responsible for driving global strategic, operational, commercial performance and …Becton, Dickinson and Company (NYSE:BDX) is a global medical technology company that specializes in the development, manufacturing, and distribution of a wide range of medical devices, laboratory ...

JHVEPhoto/iStock Editorial via Getty Images. Becton, Dickinson (NYSE:BDX) announced the acquisition of Venclose, Inc., a company that offers therapeutic options for patients with chronic venous ...

Read more on BDX stock here. Becton, Dickinson, and Company is a healthcare company with strong fundamentals and a history of dividend growth. ... (NYSE:BDX), which is part of the healthcare ...

NYSE Community. Listings Insights. What to List. How to List. Listing Process. Listing Resources. Exchange Traded Products. Listing Manager. NYSE Connect. ESG …FRANKLIN LAKES, N.J., Dec. 9, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired Tissuemed, Ltd., a privately held firm headquartered in Leeds, England that is an industry leader in developing self-adhesive surgical sealant films.FRANKLIN LAKES, N.J., Dec. 21, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced it has completed the acquisition ...Becton Dickinson stock (NYSE: BDX BDX) has seen a 7% fall this year, faring better than the broader S&P500 index, down 17%. However, in the longer term, BDX stock is down 14% from levels seen in ...Nov 25, 2023 · Becton Dickinson & Co. (NYSE:BDX)’s traded shares stood at 0.78 million during the last session, with the company’s beta value hitting 0.50. At the close of trading, the stock’s price was $238.89, to imply an increase of 0.88% or $2.09 in intraday trading. The BDX share’s 52-week high ... Dec 1, 2023 · Earnings for Becton, Dickinson and Company are expected to grow by 10.68% in the coming year, from $12.83 to $14.20 per share. Becton, Dickinson and Company has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 1st, 2024 based off prior year's report dates. Read More.

The new research reports from Fundamental Markets, available for free download at the links above, examine Brookfield Asset Management Inc (NYSE:BAM), Becton, Dickinson and Company (NYSE:BDX), IPG ...With its stock down 6.3% over the past month, it is easy to disregard Becton Dickinson (NYSE:BDX). However, the company's fundamentals look pretty decent, and long-term financials are usually ...FRANKLIN LAKES, N.J., July 28, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, announced today it has acquired MedKeeper, a ...Becton Dickinson & Co. analyst ratings, historical stock prices, earnings estimates & actuals. BDX updated stock price target summary.Nov 23, 2022 · Becton Dickinson stock (NYSE: BDX BDX) has seen a 7% fall this year, faring better than the broader S&P500 index, down 17%. However, in the longer term, BDX stock is down 14% from levels seen in ... Becton, Dickinson and Company (NYSE:BDX) Q1 2023 Earnings Call Transcript February 2, 2023 Operator: Hello, and welcome to BD’s First Fiscal Quarter of 2023 Earnings Call. At the request of BD ...NYSE: BDX. East Rutherford, New Jersey. $238.25 +2.07 (+0.88%) Share Price. as of December 1 4:00:00 PM EST. About Becton Dickinson. Becton, Dickinson & Co. is a medical technology company. The ...

FRANKLIN LAKES, N.J., Dec. 2, 2021 / PRNewswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired Venclose, Inc., a provider of solutions for the treatment of chronic venous insufficiency (CVI) — a disease that is the result of malfunctioning valves and can lead ...

Becton, Dickinson and Company's (NYSE: BDX) board approved the spinoff of its diabetes care business, which will be known as Embecta, and declared a pro rata distribution of Embecta shares of to ...Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.Get the latest Becton Dickinson and Co (BDX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …Reported EPS is $3.42 EPS, expectations were $3.42. Hello, and welcome to BD’s Fourth Quarter and Full Year Fiscal 2023 Earnings Call. At the request of BD, today’s call is being recorded and ...Friday, the FDA said that Becton, Dickinson, And Company NYSE:BDX is recalling its Alaris infusion pumps due to compatibility issues with Cardinal Health Inc's …Oct 18, 2022 · FRANKLIN LAKES, N.J., Oct. 18, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Magnolia Medical Technologies, Inc., today announced a co-exclusive commercial agreement aimed at helping U.S. hospitals reduce blood culture contamination to help improve testing accuracy and ultimately improve clinical outcomes. Nov 10, 2022 · FRANKLIN LAKES, N.J., Nov. 10, 2022 / PRNewswire / -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, an increase of 4.6% from the previous quarter. The dividend will be payable on Dec. 30, 2022 to holders of record on Dec. 9, 2022. About BDX. Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.Oct 6, 2022 · With its stock down 6.3% over the past month, it is easy to disregard Becton Dickinson (NYSE:BDX). However, the company's fundamentals look pretty decent, and long-term financials are usually ... Nov 21, 2023 · FRANKLIN LAKES, N.J., Nov. 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Ronald (Ron) Silverman, MD ...

Becton, Dickinson and Company (NYSE:BDX) has announced that it will be increasing its dividend from last year's comparable payment on the 29th of December to $0.95. This makes the dividend yield ...

FRANKLIN LAKES, N.J. (June 1, 2023) - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that Laura Boros has been named president of Pharmaceutical Systems (PS), effective today. Boros will be responsible for driving global strategic, operational and commercial …

FRANKLIN LAKES, N.J. (June 1, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that Laura Boros has been named president of Pharmaceutical Systems (PS), effective today. Boros will be responsible for driving global strategic, operational and commercial performance of the PS ...Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.NYSE: BDX. East Rutherford, New Jersey. $238.25 +2.07 (+0.88%) Share Price. as of December 1 4:00:00 PM EST. About Becton Dickinson. Becton, Dickinson & Co. is a medical technology company. The ...BD Announces Completion of Embecta Corp. Spinoff. FRANKLIN LAKES, N.J. (April 1, 2022) - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has completed its spinoff of Embecta Corp. (embecta) (NASDAQ: EMBC), which holds BD's former Diabetes Care business …Nov 10, 2022 · FRANKLIN LAKES, N.J., Nov. 10, 2022 / PRNewswire / -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, an increase of 4.6% from the previous quarter. The dividend will be payable on Dec. 30, 2022 to holders of record on Dec. 9, 2022. 12. Becton, Dickinson and Company (NYSE:BDX) Dividend Yield as of February 14: 1.50%. Number of Hedge Fund Holders: 52 Becton, Dickinson and Company (NYSE:BDX), also known simply as BD, is an ...Becton, Dickinson & Co (BDX) Medical technology company Becton, Dickinson & Co (NYSE:BDX) saw shares plummet recently on weaker-than-expected guidance. The company expects revenues of between $20. ...Becton, Dickinson and Company (NYSE:BDX) is a medical technology company which is also among the largest healthcare companies in the world by market cap. In 2021, Becton, Dickinson and Company ...Becton, Dickinson and Company (NYSE:BDX) Q4 2023 Earnings Call Transcript. Published on November 10, 2023 at 1:39 pm by Insider Monkey Transcripts in News, Transcripts. Share Tweet ...Dec 4, 2023 · Polar Capital Holdings Plc bought a new stake in Becton, Dickinson and Company (NYSE:BDX - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 134,996 shares of the medical instruments supplier's stock, valued at appr FRANKLIN LAKES, N.J., April 30, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) approval for BD ChloraPrep™ skin preparation with sterile solution, the only fully sterile chlorhexidine …Becton Dickinson and Co (NYSE:BDX) 235.80 Delayed Data As of Nov 29 +0.11 / +0.05% Today’s Change 228.62 Today ||| 52-Week Range 287.32 -7.27% Year-to-Date Quote Profile News Charts Forecasts...

Feb 19, 2023 · 12. Becton, Dickinson and Company (NYSE:BDX) Dividend Yield as of February 14: 1.50%. Number of Hedge Fund Holders: 52 Becton, Dickinson and Company (NYSE:BDX), also known simply as BD, is an ... Price. %Change. BDX. 238.89. +0.88%. You can practice and explore trading BDX stock methods without spending real money on the virtual paper trading platform. Webull offers BDX Ent Holdg (BDX) historical stock prices, in-depth market analysis, NYSE: BDX real-time stock quote data, in-depth charts, free BDX options chain data, and a fully built ...Medical technology company Becton, Dickinson & Co (NYSE: BDX) saw shares plummet recently on weaker-than-expected guidance. The company expects revenues of between $20.1 billion and $20.3 billion ...FRANKLIN LAKES, N.J., Nov. 30, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the U.S. Food and Drug Administration (FDA) Safety Communication on evaluation of certain plastic syringes: Eric Borin, …Instagram:https://instagram. usda loans for single motherswhat is the best index annuitywalmart + pricecharles schawb stock The FDA determined that another recall of BD (NYSE:BDX) Alaris infusion pumps is Class I, the most serious kind. In the latest Alaris recall, the company cites compatibility issues with Cardinal Health Monoject syringes. The issue mainly relates to changes made to the products by Cardinal Health. It affects more than 1 million total … rithmic vs tradovatepanw stok FRANKLIN LAKES, N.J., Jan. 26, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Tom Polen, BD CEO and president ...Becton, Dickinson (NYSE:BDX) has dropped nearly -10% in early trading on Thursday as investors reacted to its Q4 report. This marks the largest dip in the medical device maker's shares since ... 1 5000 leverage brokers 2 hours ago · FRANKLIN LAKES, N.J., Dec. 4, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it will present the next ... Market Data is delayed by 15 minutes and is for informational and/or educational purposes only. In certain circumstances, securities with respect to which the relevant exchange has commenced delisting proceedings may continue to be traded pending appeal of that determination.